Lab automation Archives

Interview 26 Jan 2023

Scopio on the future of telehematology

Through full-field digital cell morphology, Scopio Labs’ technology can automate the analysis of tens of thousands of cells at a time. This could mean bringing earlier detection and diagnosis of cancers, infections, and other diseases, expediting patients’ access to better care and life-saving treatments. Erez Na’aman, co-founder and CTO of Scopio Labs, tells us about […]

January 26, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 22 Dec 2022

Ganymede Bio raises $12.75M for data platform

Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, has announced a $12.75 million series A funding round, led by Caffeinated Capital. This follows a $2.9 million seed round completed earlier this year, bringing the total to more than $15.6 million. Founded in 2022, Ganymede Bio has exceeded $1 million […]

December 22, 2022 - 2 minutesmins - By Jim Cornall

Startup Scout 15 Sep 2022

Adva Biotechnology is using artificial intelligence to manufacture cell therapies

The manufacturing of cell therapies is highly complex, often depending on skilled manual labor. The Israeli startup Adva Biotechnology aims to use automation, optical sensing and artificial intelligence to remove the manual component from the process. Cancer cell therapies such as CAR-T immunotherapies have demonstrated enormous potential for treating forms of blood cancer. Currently available […]

September 15, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Jul 2022

BigHat Biosciences raises $75M to design safer, more effective antibodies

A company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today (July 20) announced it has raised $75 million in funding. BigHat Biosciences’ series B funding round was led by Section 32 with participation from new investors Amgen Ventures, Bristol Myers Squibb, Quadrille Capital, Gaingels, GRIDS Capital and others. […]

July 20, 2022 - 4 minutesmins - By Liza Laws

In Depth 19 Apr 2022

How Augmented Reality Strengthens Biotech Manufacturing

Biotech and pharma companies are starting to implement augmented reality technologies at their manufacturing facilities, bringing forth a whole new world of possibilities. The Covid-19 pandemic has been a catalyst for embracing new ways of working. Travel restrictions and limited access to facilities have pushed the adoption of technologies that enhance remote work. This is […]

April 19, 2022 - 8 minutesmins - By Carlos de Rojas

ori biotech cell therapy manufacturing cells

News and Trends 18 Jan 2022

Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture

The UK company Ori Biotech has raised €88M ($100M) in Series B cash to ease the cell therapy manufacturing bottleneck using automation and standardized data collection. The round was 40% oversubscribed and led by the US investment firm Novalis LifeSciences. The Chinese investor Puhua Capital and Chimera Abu Dhabi joined the existing syndicate, which includes […]

January 18, 2022 - 4 minutesmins - By Jonathan Smith

clinical trial, robotic automation, robot hand, lab automation

Streamlining Clinical Trial Execution with Robotic Process Automation

Conducting clinical trials on time ensures that innovative treatments can reach patients in need. In the face of logistical challenges caused by the Covid-19 pandemic, the clinical trial sector has faced major pressure to come up with innovative solutions to streamline processes and continue running trials. One such solution is robotic process automation (RPA), which […]

December 15, 2021 - 6 minutesmins - By Sudha Sundaram

Opinion 10 Nov 2021

Automation Can Solve Diversity Issues in Clinical Trial Recruitment

How can we make clinical trial recruitment more reflective of the real world? Technology is coming to the rescue. The quest for diversity in clinical trials goes to the heart of patient care. Why are some demographic groups over-represented in studies when others are more difficult to recruit? Studies that fail to reflect patient demographics […]

November 10, 2021 - 6 minutesmins - By External Contributor

Interview 22 Feb 2021

How Automation Can Augment Drug Discovery Research

Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses the benefits and challenges of introducing automation in drug discovery efforts. The Oxford-based startup Arctoris was established in 2016 with the objective of offering remote access to automated drug discovery. At a time when researchers […]

February 22, 2021 - 8 minutesmins - By External Contributor

In Depth 22 Jul 2020

Artificial Intelligence: A Superpower in the Fight Against Covid-19

The rapid spread of Covid-19 around the world has left drug developers with limited time to identify drug candidates to fight the virus. Amid this crisis, artificial intelligence has proven its value as a tool to make drug discovery faster and cost-effective. Drug discovery is an expensive, long-winded process. Taking a drug from discovery to […]

July 22, 2020 - 8 minutesmins - By David Kirk

genomics machine learning personalized medicine

News and Trends 8 May 2020

€7M Series A To Democratize Genomics with AI-Driven Cloud Software

The UK-based bioinformatics firm Lifebit Biotech has closed a €7M Series A funding round, which will help the startup to accelerate the global market expansion of its AI-driven, cloud-based genomics analysis software. The round was led by the Parisian VC firm Idinvest Partners and also included returning investors Pentech Ventures, Beacon Capital, and Connect Ventures. […]

May 8, 2020 - 3 minutesmins - By Laura Cowen

automation arctoris molecule drug discovery

News and Trends 13 Feb 2020

UK-Swiss Collaboration to Boost Biotech Profits with Automation

A partnership between the UK lab automation company Arctoris and Swiss software firm Molecule aims to make it easier to share drug intellectual property in a time of declining returns in pharma. The pharmaceutical industry is struggling with the rising costs of developing new drugs. In fact, the return on investment for drug discovery is […]

February 13, 2020 - 3 minutesmins - By Jonathan Smith

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Lab automation

Scopio on the future of telehematology

Ganymede Bio raises $12.75M for data platform

Adva Biotechnology is using artificial intelligence to manufacture cell therapies

BigHat Biosciences raises $75M to design safer, more effective antibodies

How Augmented Reality Strengthens Biotech Manufacturing

Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture

Streamlining Clinical Trial Execution with Robotic Process Automation

Automation Can Solve Diversity Issues in Clinical Trial Recruitment

How Automation Can Augment Drug Discovery Research

Artificial Intelligence: A Superpower in the Fight Against Covid-19

€7M Series A To Democratize Genomics with AI-Driven Cloud Software

UK-Swiss Collaboration to Boost Biotech Profits with Automation

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!